Literature DB >> 6477054

The design of the Epidemiologic Catchment Area surveys. The control and measurement of error.

W W Eaton, C E Holzer, M Von Korff, J C Anthony, J E Helzer, L George, A Burnam, J H Boyd, L G Kessler, B Z Locke.   

Abstract

Several methods are used to minimize and measure error in the NIMH Epidemiologic Catchment Area program. Sampling methods involve the inclusion of group quarters such as prisons, nursing homes, and mental hospitals in the sample frame and the use of probability sampling throughout. Interviewing, methods include use of identical diagnostic interview protocols, centralized training of interview supervisors, standard instructions to interviewers, and reinterview of a subsample by clinicians. In the area of completion, the methods include a 75% to 80% respondent completion rate, a 95% or greater completion rate for individual questions, use of informant interviews where necessary, and statistical adjustments to correct for low completion rates in some subgroups. Analytic methods include use of a computerized diagnostic algorithm, common estimation formulas on identically formatted data files, and estimation of exact variances that take account of the multistage sample design.

Mesh:

Year:  1984        PMID: 6477054     DOI: 10.1001/archpsyc.1984.01790210024004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  30 in total

1.  Asthma, suicidal ideation, and suicide attempts: findings from the Baltimore epidemiologic catchment area follow-up.

Authors:  Renee D Goodwin; William W Eaton
Journal:  Am J Public Health       Date:  2005-04       Impact factor: 9.308

2.  An epidemiologic investigation of potential risk factors for suicide attempts.

Authors:  K R Petronis; J F Samuels; E K Moscicki; J C Anthony
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-07       Impact factor: 4.328

3.  Antisocial personality and risks of cause-specific mortality: results from the Epidemiologic Catchment Area study with 27 years of follow-up.

Authors:  Anna Krasnova; William W Eaton; Jack F Samuels
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-12-01       Impact factor: 4.328

Review 4.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

5.  Mortality among heroin users and users of other internationally regulated drugs: A 27-year follow-up of users in the Epidemiologic Catchment Area Program household samples.

Authors:  Catalina Lopez-Quintero; Kimberly B Roth; William W Eaton; Li-Tzy Wu; Linda B Cottler; Martha Bruce; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2015-09-03       Impact factor: 4.492

6.  Population-based study of first onset and chronicity in major depressive disorder.

Authors:  William W Eaton; Huibo Shao; Gerald Nestadt; Hochang Benjamin Lee; Ben Hochang Lee; O Joseph Bienvenu; Peter Zandi
Journal:  Arch Gen Psychiatry       Date:  2008-05

Review 7.  Epidemiology of depression.

Authors:  J Angst
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women.

Authors:  Arnstein Mykletun; Felice Jacka; Lana Williams; Julie Pasco; Margaret Henry; Geoffrey C Nicholson; Mark A Kotowicz; Michael Berk
Journal:  BMC Gastroenterol       Date:  2010-08-05       Impact factor: 3.067

9.  Phobia: prevalence and risk factors.

Authors:  J H Boyd; D S Rae; J W Thompson; B J Burns; K Bourdon; B Z Locke; D A Regier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-11       Impact factor: 4.328

10.  Mental health services use: Baltimore epidemiologic catchment area follow-up.

Authors:  Hillary R Bogner; Heather F de Vries; Pallab K Maulik; Jürgen Unützer
Journal:  Am J Geriatr Psychiatry       Date:  2009-08       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.